WFDC2 and ovarian carcinoma: In this study, CA-125, HE4, CEA, and VCAM-1 demonstrated as the highest diagnostic biomarker combination for early stage ovarian cancer achieving the sensitivity of 86 % and specificity of 98 % when validated in a training set.